Trademark Overview
On Monday, March 4, 2024, a trademark application was filed for NEUEXCELL with the United States Patent and Trademark Office. The USPTO has given the NEUEXCELL trademark a serial number of 98432310. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 24, 2024. This trademark is owned by NeuExcell Therapeutics Inc.. The NEUEXCELL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
